(Q33763394)

English

Patients with the malignant profile within 3 hours of symptom onset have very poor outcomes after intravenous tissue-type plasminogen activator therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Patients with the malignant profile within 3 hours of symptom onset have very poor outcomes after intravenous tissue-type plasminogen activator therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

author name string

Manabu Inoue

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Michael Mlynash

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Matus Straka

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Maarten G Lansberg

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Greg Zaharchuk

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Roland Bammer

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Gregory W Albers

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

17 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

2494-2496

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059671

14 July 2018

Real-time diffusion-perfusion mismatch analysis in acute stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059671

14 July 2018

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059671

14 July 2018

Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059671

30 October 2018

Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059671

30 October 2018

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22811464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1161/STROKEAHA.112.653329

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33763394&oldid=1966638684"